Meta-analyses of FibroTest diagnostic value in chronic liver disease
<p>Abstract</p> <p>Background</p> <p>FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC).</p> <p>The aim was to test two hypotheses, one, that the FT diagnostic value was similar in the three other f...
Main Authors: | Bourliere Marc, Zoulim Fabien, Lebrec Didier, Thabut Dominique, Naveau Sylvie, Imbert-Bismut Françoise, Castera Laurent, Ratziu Vlad, Halfon Philippe, Morra Rachel, Poynard Thierry, Cacoub Patrice, Messous Djamila, Munteanu Mona, de Ledinghen Victor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/7/40 |
Similar Items
-
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
by: Munteanu Mona, et al.
Published: (2006-02-01) -
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
by: Messous Djamila, et al.
Published: (2011-04-01) -
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.
by: Yen Ngo, et al.
Published: (2008-07-01) -
Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load.
by: Yen Ngo, et al.
Published: (2008-01-01) -
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
by: Bismut Françoise, et al.
Published: (2010-04-01)